Tìm theo
GV1001
Thuốc điều trị ung thư
Thuốc Gốc
Biotech
GV1001 is a peptide vaccine that activates the immune system so that it recognizes and kills cancer cells. It is being developed by Pharmexa A/S.
Dược Lực Học : GV1001 is a peptide vaccine that activates the immune system so that it recognises and kills cancer cells.
Cơ Chế Tác Dụng : GV1001 is a peptide vaccine that activates the immune system so that it recognizes and kills cancer cells. It is being developed by Pharmexa A/S. GV1001 targets an enzyme called telomerase. Telomerase is seldom found in normal cell types but is overexpressed in most cancer cells.
Chỉ Định : Investigated for use/treatment in hepatocellular carcinoma, lung cancer, and pancreatic cancer.
Tài Liệu Tham Khảo Thêm
drugbank
http://www.drugbank.ca/drugs/DB04937
... loading
... loading